Annual long term debt:
$849.87M-$43.03M(-4.82%)Summary
- As of today (September 16, 2025), RARE annual long term debt is $849.87 million, with the most recent change of -$43.03 million (-4.82%) on December 31, 2024.
- During the last 3 years, RARE annual long term debt has risen by +$467.18 million (+122.08%).
- RARE annual long term debt is now -5.07% below its all-time high of $895.25 million, reached on December 31, 2022.
Performance
RARE Long term debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly long term debt:
$807.28M-$14.55M(-1.77%)Summary
- As of today (September 16, 2025), RARE quarterly long term debt is $807.28 million, with the most recent change of -$14.55 million (-1.77%) on June 30, 2025.
- Over the past year, RARE quarterly long term debt has dropped by -$60.62 million (-6.98%).
- RARE quarterly long term debt is now -11.34% below its all-time high of $910.55 million, reached on September 30, 2023.
Performance
RARE Quarterly long term debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Long term debt Formula
Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt
RARE Long term debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -4.8% | -7.0% |
| 3 y3 years | +122.1% | +109.8% |
| 5 y5 years | +146.3% | +123.0% |
RARE Long term debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -5.1% | +122.1% | -11.3% | +109.8% |
| 5 y | 5-year | -5.1% | +146.3% | -11.3% | +123.0% |
| alltime | all time | -5.1% | >+9999.0% | -11.3% | >+9999.0% |
RARE Long term debt History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $807.28M(-1.8%) |
| Mar 2025 | - | $821.83M(-3.3%) |
| Dec 2024 | $849.87M(-4.8%) | $849.87M(-0.4%) |
| Sep 2024 | - | $853.34M(-1.7%) |
| Jun 2024 | - | $867.90M(-1.0%) |
| Mar 2024 | - | $876.70M(-1.8%) |
| Dec 2023 | $892.90M(-0.3%) | $892.90M(-1.9%) |
| Sep 2023 | - | $910.55M(+1.6%) |
| Jun 2023 | - | $895.84M(-0.9%) |
| Mar 2023 | - | $903.82M(+1.0%) |
| Dec 2022 | $895.25M(+133.9%) | $895.25M(+1.2%) |
| Sep 2022 | - | $884.93M(+129.9%) |
| Jun 2022 | - | $384.84M(+0.3%) |
| Mar 2022 | - | $383.68M(+0.3%) |
| Dec 2021 | $382.69M(+2.1%) | $382.69M(+0.3%) |
| Sep 2021 | - | $381.42M(+0.4%) |
| Jun 2021 | - | $379.90M(+0.8%) |
| Mar 2021 | - | $376.96M(+0.5%) |
| Dec 2020 | $374.92M(+8.6%) | $374.92M(+2.0%) |
| Sep 2020 | - | $367.70M(+1.5%) |
| Jun 2020 | - | $362.09M(+1.8%) |
| Mar 2020 | - | $355.79M(+3.1%) |
| Dec 2019 | $345.13M | $345.13M(+1006.0%) |
| Sep 2019 | - | $31.21M(-5.3%) |
| Jun 2019 | - | $32.97M(+43.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $22.98M(>+9900.0%) |
| Dec 2018 | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2018 | - | $0.00(0.0%) |
| Mar 2018 | - | $0.00(0.0%) |
| Dec 2017 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2017 | - | $0.00(0.0%) |
| Jun 2017 | - | $0.00(0.0%) |
| Mar 2017 | - | $0.00(0.0%) |
| Dec 2016 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2016 | - | $0.00(0.0%) |
| Jun 2016 | - | $0.00(0.0%) |
| Mar 2016 | - | $0.00(0.0%) |
| Dec 2015 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2015 | - | $0.00(0.0%) |
| Jun 2015 | - | $0.00(0.0%) |
| Mar 2015 | - | $0.00(0.0%) |
| Dec 2014 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2014 | - | $0.00(0.0%) |
| Jun 2014 | - | $0.00(0.0%) |
| Mar 2014 | - | $0.00(0.0%) |
| Dec 2013 | - | $0.00(0.0%) |
| Sep 2013 | - | $0.00(0.0%) |
| Jun 2013 | - | $0.00(0.0%) |
| Dec 2012 | $0.00(0.0%) | $0.00 |
| Dec 2011 | $0.00 | - |
FAQ
- What is Ultragenyx Pharmaceutical Inc. annual long term debt?
- What is the all time high annual long term debt for Ultragenyx Pharmaceutical Inc.?
- What is Ultragenyx Pharmaceutical Inc. annual long term debt year-on-year change?
- What is Ultragenyx Pharmaceutical Inc. quarterly long term debt?
- What is the all time high quarterly long term debt for Ultragenyx Pharmaceutical Inc.?
- What is Ultragenyx Pharmaceutical Inc. quarterly long term debt year-on-year change?
What is Ultragenyx Pharmaceutical Inc. annual long term debt?
The current annual long term debt of RARE is $849.87M
What is the all time high annual long term debt for Ultragenyx Pharmaceutical Inc.?
Ultragenyx Pharmaceutical Inc. all-time high annual long term debt is $895.25M
What is Ultragenyx Pharmaceutical Inc. annual long term debt year-on-year change?
Over the past year, RARE annual long term debt has changed by -$43.03M (-4.82%)
What is Ultragenyx Pharmaceutical Inc. quarterly long term debt?
The current quarterly long term debt of RARE is $807.28M
What is the all time high quarterly long term debt for Ultragenyx Pharmaceutical Inc.?
Ultragenyx Pharmaceutical Inc. all-time high quarterly long term debt is $910.55M
What is Ultragenyx Pharmaceutical Inc. quarterly long term debt year-on-year change?
Over the past year, RARE quarterly long term debt has changed by -$60.62M (-6.98%)